-
In early December 2025, Bapcor cut its FY26 statutory and underlying NPAT guidance, flagged a A$5 million–A$8 million first‑half loss driven by underperformance in its Trade and tools and equipment segments, and continued restructuring that includes one‑off costs and balance sheet pressure.
-
Against this backdrop of repeated profit downgrades and a tougher‑than‑planned turnaround, Bapcor also announced the upcoming resignation of Lead Independent Director Mark Powell and saw a substantial shareholder, Antipodes Partners, exit its position, raising fresh questions about governance stability and investor confidence.
-
We'll now examine how the deeper‑than‑expected FY26 profit downgrade, especially in the Trade segment, reshapes Bapcor's previously optimistic investment narrative.
Explore 27 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
Bapcor Investment Narrative Recap
To stay invested in Bapcor today, you need to believe the turnaround can stabilise the Trade division and restore earnings while the balance sheet remains manageable. The sharp FY26 profit downgrade and guidance for a A$5 million to A$8 million first half loss directly weakens that near term earnings recovery catalyst and amplifies the key risk that repeated missteps further erode customer loyalty and lender confidence.
The most relevant update is Bapcor's cut to FY26 statutory NPAT guidance to A$31 million to A$36 million and underlying NPAT to A$44 million to A$49 million, driven by Trade and tools underperformance and restructuring costs. This turns what was framed as a gradual operational reset into a more pressured turnaround, where execution on cost savings and pricing changes now has far less room for error.
But against all this, investors should be aware that Bapcor is also seeking higher leverage covenants with its lenders, which...
Read the full narrative on Bapcor (it's free!)
Bapcor's narrative projects A$2.1 billion revenue and A$106.9 million earnings by 2028. This requires 2.2% yearly revenue growth and about A$78.8 million earnings increase from A$28.1 million today.
Uncover how Bapcor's forecasts yield a A$3.21 fair value , a 80% upside to its current price.
Exploring Other Perspectives
Seven Simply Wall St Community members currently estimate Bapcor's fair value between A$2.62 and A$6.38, showing a wide spread of opinions. Against this, the latest profit warning and first half loss guidance put renewed focus on whether the turnaround and restructuring can actually restore margins and protect the balance sheet over time, so it is worth comparing several of these different views before forming your own.
Explore 7 other fair value estimates on Bapcor - why the stock might be worth just A$2.62!
Build Your Own Bapcor Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
-
A great starting point for your Bapcor research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
-
Our free Bapcor research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Bapcor's overall financial health at a glance.
No Opportunity In Bapcor?
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
-
Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit .
-
AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery . The best part - they are all under $10b in market cap - there's still time to get in early.
-
We've found 12 US stocks that are forecast to pay a dividend yield of over 6% next year . See the full list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BAP.AX .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
